✦ LIBER ✦

Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction: Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)

✍ Scribed by Elliott M. Antman; David A. Morrow; Carolyn H. McCabe; Frank Jiang; Harvey D. White; Keith A.A. Fox; Divakar Sharma; Paul Chew; Eugene Braunwald

Book ID: 116189867
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 631 KB
Volume: 149
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2004.08.038

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of enoxaparin versus unfractionat

Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment–Thrombolysis In Myocardial Infarction study 25 (ExTRACT–TIMI 25) trial

✍ David A. Morrow; Elliott M. Antman; Sabina A. Murphy; Jie Qin; Mikhail Ruda; Sem 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 379 KB

Global outcomes of ST-elevation myocardi

Global outcomes of ST-elevation myocardial infarction: Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial

✍ Benjamin A. Steinberg; Nazanin Moghbeli; Jacqueline Buros; Mikhail Ruda; Alexand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Cost-effectiveness of enoxaparin compare

Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: A Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment – Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial

✍ Robert C. Welsh; Luc Sauriol; Zugui Zhang; Paul Kolm; William S. Weintraub; Pier 📂 Article 📅 2009 🏛 Pulsus Group Inc 🌐 English ⚖ 709 KB

The safety and efficacy of subcutaneous

The safety and efficacy of subcutaneous enoxaparin vs. intravenous unfractionated heparin and tirofiban vs. placebo in the treatment of acute st-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial

✍ M Cohen; G.F Gensini; F Maritzet al 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 45 KB

The TETAMI Trial: The Safety and Efficac

The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design

✍ Marc Cohen; Frans Maritz; Gian Franco Gensini; Nicolas Danchin; Ari Timerman; Ku 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 93 KB